CYPKEENA

Serial Number 97911202
606

Registration Progress

Application Filed
Apr 27, 2023
Under Examination
May 7, 2024
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered

Trademark Image

CYPKEENA

Basic Information

Serial Number
97911202
Filing Date
April 27, 2023
Published for Opposition
March 12, 2024
Abandonment Date
June 9, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 9, 2025
Classes
005

Rights Holder

MIRUM PHARMACEUTICALS, INC.

03
Address
989 E Hillsdale Blvd., Suite 300
FOSTER CITY, CA 94404

Ownership History

Travere Therapeutics, Inc.

Original Applicant
03
SAN DIEGO, CA

Travere Therapeutics, Inc.

Owner at Publication
03
SAN DIEGO, CA

MIRUM PHARMACEUTICALS, INC.

New Owner After Publication #1
03
FOSTER CITY, CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Jun 9, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 9, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 6, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 6, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 6, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 1, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 1, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 25, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 25, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 25, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 25, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 25, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 8, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 7, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 31, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 31, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 16, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 16, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 16, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 16, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 16, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 1, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, cerebrotendinous xanthomatosis (CTX)

Classification

International Classes
005